NCT02232516 2024-04-10Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell LymphomaNorthwestern UniversityPhase 2 Active not recruiting30 enrolled 17 charts
NCT02561273 2023-12-13Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's LymphomaUniversity of NebraskaPhase 1/2 Completed54 enrolled 14 charts
NCT01075321 2020-10-22Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed58 enrolled 12 charts
NCT01419795 2017-07-27Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Terminated3 enrolled 10 charts
NCT01116154 2010-12-09Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaCity of Hope Medical CenterPhase 1 Terminated30 enrolled